Jyothis is an entrepreneurial physician-scientist with a track-record in global leadership. Leading clinical development of BI’s cardio-metabolic portfolio (which includes two blockbusters – Empagliflozin and Linagliptin) His global outcome-trial leadership includes the pragmatic trial EXSCEL, the active-comparator trial CAROLINA, the CARMELINA trial with a renal-enriched population and the EMPEROR Heart Failure Program. This decade-long experience…Read more